Burnt Out? The Phenomenon of Type 2 Diabetes Mellitus in End-Stage Renal Disease

Chandler D Schexnayder; Sylvester Agbahiwe; Oluchi Emelogu

doi:10.12788/fp.0076

Burnt Out? The Phenomenon of Type 2 Diabetes Mellitus in End-Stage Renal Disease

Fed Pract. 2020 Dec;37(12):580-585. doi: 10.12788/fp.0076.

Authors

Chandler D Schexnayder¹, Sylvester Agbahiwe¹, Oluchi Emelogu¹

Affiliation

¹ is a Home-Based Primary Care Clinical Pharmacy Specialist, and is a Primary Care Clinical Pharmacy Specialist, both at the Michael E. DeBakey Veteran Affairs Medical Center in Houston, Texas. is a Primary Care Clinical Pharmacy Specialist at the Audie L. Murphy Memorial Veterans' Hospital in San Antonio, Texas.

Abstract

In patients with T2DM and ESRD, insulin is the antidiabetic medication of choice with a hemoglobin A_1c target of 6 to 8%, using fructosamine levels or other measures for better assessment of glycemic control.